Management of relapsing disease in prostate cancer-Reference-Cited by-同舟云学术

Management of relapsing disease in prostate cancer

Published:1992-07-01 Issue:S1 Volume:70 Page:329-334
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Mahler Charles,Denis Louis

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference79 articles.

1. ENDOCRINE CONTROL OF PROSTATIC CARCINOMA

2. Adrenal Suppression in the Treatment of Carcinoma of the Prostate

3. Sch 13521 In The Treatment Of Advanced Carcinoma Of The Prostate

4. Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy

5. , , , , , et al. The importance of combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in previously untreated as well as previously treated patients with advanced prostate cancer. In: , , eds. Hormonal manipulation of cancer: peptides, growth factors and (anti)-steroidal agents. New York: Raven Press, 1986; 291–300.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Xenografts on nude mouse diaphragm of human DU145 prostate carcinoma cells: mesothelium removal by outgrowths and angiogenesis;Ultrastructural Pathology;2022-09-03

2. Arsenic trioxide inhibits viability and induces apoptosis through reactivating the Wnt inhibitor secreted frizzled related protein-1 in prostate cancer cells;OncoTargets and Therapy;2016-02

3. Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines;PLOS ONE;2015-06-03

4. γ-oryzanol reduces caveolin-1 and PCGEM1 expression, markers of aggressiveness in prostate cancer cell lines;The Prostate;2015-01-25

5. Quercetin regulates insulin like growth factor signaling and induces intrinsic and extrinsic pathway mediated apoptosis in androgen independent prostate cancer cells (PC-3);Molecular and Cellular Biochemistry;2010-07-25